XTRAC Laser Provides New Hope for Children with Psoriasis
MONTGOMERYVILLE, Pa., June 8, 2011 /PRNewswire/ -- About 20,000 children in the United States under the age of 10 are diagnosed with psoriasis every year. For many, the disease goes beyond painful red, dry patches of scaly, thickened skin; the emotional side-effects are equally life altering—with nearly 50 percent of children reporting that they have been bullied because of their disease. The XTRAC® Excimer Laser (www.XTRACLaser.com ) offers new hope for this often underserved population, giving children a safe and effective treatment option that provides relief without the negative side-effects commonly associated with other psoriasis treatments.
Developed by PhotoMedex , Inc. (NASDAQ: PHMD ), an innovator of medical devices, the XTRAC laser is a proven, FDA-cleared phototherapy treatment for psoriasis that uses a carefully focused beam of UVB light only on the affected area without exposing healthy skin to UVB rays. While medications and creams are generally accepted to be a patient's only option, parents should know that they can get better—and safer—results for their children with XTRAC laser treatments.
"The XTRAC laser provides mild-to-severe psoriasis sufferers with long-term relief, with remission periods lasting four to six months and often up to a year," said Ronald Glick, D.O., Dermatology & Cosmetic Surgery, PC in Phoenix, Ariz. "It allows children to be carefree and avoid the social stigmas often associated with the disease. Psoriasis can have a daunting emotional impact. It often contributes to anxiety, low self-esteem, difficulty sleeping and bouts of depression in children and teens."
In a National Psoriasis Foundation survey of children with psoriasis, 44 percent of kids reported they have been bullied by their peers, and 38 per